This profile was last updated on .
Is this you? Claim your profile.
Redx Pharma Ltd
Redx Pharma is developing novel neuraminidase inhibitors with the potential for improved efficacy and ease-of-use compared to existing anti-virals.
The neuraminidase inhibitors oseltamivir (Tamiflu - Roche) and zanamivir (Relenza - GSK) are, along with ...
Find other employees at this company (173)
(200 Total References)
Neil Murray, CEO of ...
Neil Murray, CEO of Redx Pharma Plc, the drug development company based at Alderley Park, Cheshire, said: "The UK has a compelling offer to biotech, with one of the strongest and most productive life science sectors in the world and a tax regime that is increasingly favourable for R&D-based businesses.
International Festival For Business 2014 â€“ Influential
Neil Sturmey of Grant Thornton and Dr Neil Murray of Redx Pharma joined North West business leaders in reacting to the opening phase of IFB 2014.
Chancellor visits Redx Pharma labs â€“ Influential
Left to right; Ruth McKernan, CEO of Innovate UK; Neil Murray CEO of Redx Pharma; Chris Doherty, Alderley Park's site director; George Osborne, Chancellor of the Exchequer; Professor Ian Greer, University of Manchester's Dean of Medicine; Derek Lindsay, COO of Redx Pharma; John McKinley, CEO of Precision Medicines Catapult; Peter Jackson, non-executive director of Redx Pharma.
"It was a pleasure to meet the Chancellor and we welcomed the opportunity to showcase the outstanding science that our staff produce in infectious disease, cancer and immunology," said Redx chief executive Neil Murray.
Neil Murray, Chief Executive ...
Neil Murray, Chief Executive of Redx, commented: "We are delighted to announce the appointment of David as Non-Executive Director and would like to welcome him to the Board.
- Neil Murray, CEO Redx Pharma Plc